2025
SJR Q2
JCR Q2 · 2,8
OA
22 matched articles
SCIE
Journal detail
Advances in Rheumatology
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
25233106
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,722
- Quartile Q2
- H-Index 45
- Cites/doc 2,62
- Docs (3y) 194
- Cites (3y) 505
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,8
- 5Y JIF 2,7
- JCI 0,71
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Rheumatology Q2
Areas
- Medicine
WoS categories
- Rheumatology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,722 | 2,8 | 2,7 | 0,71 | Q2 | 45 |
| 2024 | Q3 | Q3 | 0,645 | 2,1 | 2,5 | 0,63 | Q3 | 43 |
| 2023 | Q2 | Q3 | 0,704 | 2 | 2,6 | 0,58 | Q2 | 43 |
| 2022 | Q3 | Q4 | 0,686 | 2,3 | 2,9 | 0,59 | Q2 | 43 |
| 2021 | Q2 | Q3 | 0,669 | 3 | 3,1 | 0,58 | Q3 | 43 |
| 2020 | Q3 | Q4 | 0,524 | 2,2 | 2,2 | 0,44 | Q3 | 43 |
| 2019 | Q3 | Q4 | 0,435 | 0,9 | 0,9 | 0,24 | Q4 | 43 |
| 2018 | — | — | — | — | — | — | — | — |
| 2017 | — | — | — | — | — | — | — | 43 |
| 2016 | — | — | — | — | — | — | — | 43 |
| 2015 | — | — | — | — | — | — | — | 43 |
| 2014 | — | — | — | — | — | — | — | 43 |
| 2013 | — | — | — | — | — | — | — | 43 |
| 2012 | — | — | — | — | — | — | — | 43 |
| 2011 | — | — | — | — | — | — | — | 43 |
| 2010 | — | — | — | — | — | — | — | 43 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | RHEUMATOLOGY | SCIE | Q2 | Q2 | 27/58 |
| 2024 | RHEUMATOLOGY | SCIE | Q3 | Q3 | 32/58 |
| 2023 | RHEUMATOLOGY | SCIE | Q3 | Q2 | 34/57 |
| 2022 | RHEUMATOLOGY | SCIE | Q4 | Q2 | 26/34 |
| 2021 | RHEUMATOLOGY | SCIE | Q3 | Q3 | 25/34 |
| 2020 | RHEUMATOLOGY | SCIE | Q4 | Q3 | 30/34 |
| 2019 | RHEUMATOLOGY | SCIE | Q4 | Q4 | 30/32 |
| 2018 | RHEUMATOLOGY | SCIE | — | — | — |